论文部分内容阅读
糖化血红蛋白(HbA1c)是糖尿病控制和治疗监测的重要标准。世界卫生组织和美国、英国、澳大利亚等国家的糖尿病协会,已经推荐采用HbA1c为糖尿病的诊断标准之一[1]。HbA1c的诊断切点,即HbA1c≥6.5%(48mmol/L),由国外的研究得出,尚缺少我国的数据;且样本来自健康人群。虽然不推荐使用HbA1c来诊断妊娠期糖尿病(GDM)[2],但是HbA1c作为血糖控制的监测指标,对GDM的进展仍有重要价值。HbA1c在妊娠人群中的参考
Glycated hemoglobin (HbA1c) is an important standard for the monitoring and treatment of diabetes. WHO and the United States, Britain, Australia and other countries Diabetes Association, has recommended the use of HbA1c as one of the diagnostic criteria for diabetes [1]. HbA1c diagnostic cutoff point, that is, HbA1c≥6.5% (48mmol / L), obtained from foreign studies, but still lacking our data; and samples from healthy people. Although HbA1c is not recommended for the diagnosis of gestational diabetes mellitus (GDM) [2], HbA1c, as a measure of glycemic control, remains valuable for the progression of GDM. Reference for HbA1c in Pregnancy